What is Delta-3-Carene?
Delta-3-Carene is a naturally occurring terpene with the molecular formula C10H16. It has a compact bicyclic structure consisting of a six-carbon ring connected to a three-carbon ring.
This small three-carbon ring makes Delta-3-Carene structurally distinct from many other common monoterpenes. It is found naturally in a range of plants and is especially well known as a major component of some pine and spruce oils.
Reported effects
Delta-3-Carene has been studied mainly in animal and laboratory models. Research supports calming and sedating effects on the nervous system, together with pain and inflammation reduction.
Calming
Animal studiesDelta-3-Carene has been associated with anxiety-reducing effects in animal research. Its ability to strengthen inhibitory GABA-A signalling provides a plausible mechanism for a more calming nervous-system response.
Sedating
Animal studiesDelta-3-Carene increased sleep duration and reduced the time needed to fall asleep in mice when combined with pentobarbital. These effects were linked directly to increased GABA-A receptor signalling.
Pain & inflammation
Preclinical studiesDelta-3-Carene has reduced pain responses, swelling and inflammatory immune-cell activity in several animal models. Effects have been observed in both acute and long-lasting inflammation, including reductions in mechanical pain sensitivity.
Molecular targets
The clearest direct molecular target identified for Delta-3-Carene is the GABA-A receptor, one of the main inhibitory signalling systems in the brain.
GABA-A receptor
GABA-A is one of the main inhibitory receptors in the brain and helps reduce electrical activity between nerve cells.
Delta-3-Carene acts as a positive modulator of GABA-A signalling. Brain-slice experiments showed that it prolonged inhibitory signals with an EC50 of approximately 48.8 nM.
Flumazenil, which blocks the benzodiazepine site of the GABA-A receptor, prevented both this receptor effect and the sleep-enhancing effects of Delta-3-Carene in mice.
These findings provide strong evidence that the GABA-A receptor is a direct molecular target of Delta-3-Carene.